These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9476746)

  • 1. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
    Hylan TR; Crown WH; Meneades L; Heiligenstein JH; Melfi CA; Croghan TW; Buesching DP
    J Affect Disord; 1998 Jan; 47(1-3):71-9. PubMed ID: 9476746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term costs of treatment for depression: impact of drug selection and guideline adherence.
    Crown WH; Treglia M; Meneades L; White A
    Value Health; 2001; 4(4):295-307. PubMed ID: 11705297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans.
    Polsky D; Onesirosan P; Bauer MS; Glick HA
    J Clin Psychiatry; 2002 Feb; 63(2):156-64. PubMed ID: 11874218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.
    Sclar DA; Robison LM; Skaer TL; Galin RS; Legg RF; Nemec NL; Hughes TE; Buesching DP; Morgan M
    J Int Med Res; 1995; 23(6):395-412. PubMed ID: 8746607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
    Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
    Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic appraisal of citalopram in the management of single-episode depression.
    Sclar DA; Skaer TL; Robison LM; Galin RS
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline. A pharmacoeconomic evaluation of its use in depression.
    Davis R; Wilde MI
    Pharmacoeconomics; 1996 Oct; 10(4):409-31. PubMed ID: 10184609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
    Russell JM; Berndt ER; Miceli R; Colucci S; Grudzinski AN
    Am J Manag Care; 1999 May; 5(5):597-606. PubMed ID: 10537866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing SSRI treatment costs for depression using retrospective claims data: the role of nonrandom selection and skewed data.
    Berndt ER; Russell JM; Miceli R; Colucci SV; Xu Y; Grudzinski AN
    Value Health; 2000; 3(3):208-21. PubMed ID: 16464185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.
    Sclar DA; Skaer TL; Robison LM; Galin RS; Legg RF; Nemec NL
    J Clin Psychiatry; 1998; 59 Suppl 2():13-7. PubMed ID: 9559755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of major selective serotonin-reuptake inhibitors in a managed care population.
    Panzarino PJ; Xuan J
    Manag Care Interface; 2001 Apr; 14(4):59-65. PubMed ID: 11339023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
    Boyer P; Danion JM; Bisserbe JC; Hotton JM; Troy S
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):157-69. PubMed ID: 10184835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antidepressant choice on the incidence and economic intensity of hospitalization among depressed individuals.
    Croghan TW; Kniesner TJ; Melfi CA; Robinson RL
    Adm Policy Ment Health; 2000 Mar; 27(4):183-95. PubMed ID: 10911668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.
    Hylan TR; Crown WH; Meneades L; Heiligenstein JH; Melfi CA; Croghan TW; Buesching DP
    Med Care; 1999 Apr; 37(4 Suppl Lilly):AS36-44. PubMed ID: 10217392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
    Dewa CS; Hoch JS; Goering P
    Clin Ther; 2001 Feb; 23(2):292-306. PubMed ID: 11293562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year costs of second-line therapies for depression.
    Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.